[Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)].
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D001769:Blood; D002509:Cephaloridine / Q000494:pharmacology / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use; D004355:Drug Stability; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D006863:Hydrogen-Ion Concentration; D008297:Male; D051379:Mice; D010405:Penicillinase; D011008:Pneumococcal Infections / Q000188:drug therapy; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D012996:Solutions; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D013830:Thiadiazoles / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D002511:Cephalosporins; D011725:Pyridines; D012996:Solutions; D013777:Tetrazoles; D013830:Thiadiazoles; D010405:Penicillinase; D002509:Cephaloridine; D002512:Cephalothin